Target intelligence / Profile preview

Ribosomal protein L41 (RPL41)

Target
RPL41
Molecular classification
Other, Ribosomal protein
01

Overview

Ribosomal protein L41 (RPL41) is a very small, basic component of the large ribosomal subunit, consisting of 25 amino acids[1][2][3]. It plays several vital roles in cellular biology, including maintenance of mitotic progression, proper chromosomal segregation, and cytoskeletal integrity by stabilizing polymerized tubulins[1][2]. Depletion of RPL41 disrupts spindle formation and centrosome integrity, leading to failed cytokinesis and aneuploidy—events linked to malignant transformation, supporting a tumor suppressor function for this protein[1][2]. RPL41 also promotes the proteasomal degradation of the stress-responsive transcription factor ATF4, causing cell cycle arrest and increased sensitivity of tumor cells to chemotherapy[1]. While often downregulated in cancer, RPL41 can also be upregulated in some malignancies, suggesting context-dependent regulation and a complex role in tumorigenesis[1][2][3].

Other names
L41eL4160S ribosomal protein L41HG12homologue of yeast ribosomal protein YL41large ribosomal subunit protein eL41small ribosomal subunit protein eS32RL41_HUMAN
02

Mechanism of action

Sensitization of tumor cells to chemotherapeutic agents via ATF4 degradation and increased susceptibility to DNA-damaging drugs

03

Biological functions

Cytoplasmic translationmRNA bindingChromosomal segregationMitotic progressionRegulation of microtubule stabilityCentrosome integrityRegulation of transcription factor ATF4 degradation
04

Disease associations

CancerTumor suppressionDiamond-Blackfan anemia
05

Interacting drugs

Cisplatin

1 more in the full profile.

06

Biomarkers

RPL41 expression levels in tumors (potential biomarker for tumor subtype/cancer progression)

Beyond the preview

Go deeper on Ribosomal protein L41 (RPL41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L41 (RPL41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call